0078-0393 : Simulect 10 mg/2.5ml Intravenous Injection, Powder, for Solution
NDC: | 0078-0393 |
Labeler: | Novartis Pharmaceuticals Corporation |
Product Type: | Human Prescription Drug |
Drug Name: | Simulect |
Dosage Form: | Intravenous Injection, Powder, for Solution |
Application #: | BLA103764 |
Rev. Date: |
NDC Package Codes:
- 0078-0393-61: 1 VIAL, SINGLE‑USE IN 1 CARTON (0078‑0393‑61) > 2.5 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Basiliximab
Dosage Strength:
- 10 mg/2.5mL
Pharmaceutical Classes:
- Interleukin 2 Receptor Antagonists [MoA]
- Interleukin 2 Receptor-directed Antibody Interactions [MoA]
- Interleukin-2 Receptor Blocking Antibody [EPC]
Related Products:
Based on records with the same trade name.- 0078-0331 Simulect 20 mg/5ml Intravenous Injection, Powder, for Solution by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0078-0387Next: 0078-0400 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.